Intravascular B-cell lymphoma: case report of a rare cause of pulmonary arterial hypertension.
Case report
Cor pulmonale
Intravascular lymphoma
Pulmonary hypertension
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
18
06
2018
accepted:
02
01
2019
entrez:
26
4
2019
pubmed:
26
4
2019
medline:
26
4
2019
Statut:
epublish
Résumé
Intravascular large B-cell lymphoma (IVLBCL) is a rare disease characterized by proliferation of malignant lymphoid cells within the small vessels of various organs resulting in diffuse thrombosis. It most commonly affects the central nervous system and the skin, but if it involves the pulmonary arteries it can cause acute severe pulmonary hypertension (PH) and right heart failure. Early diagnosis is essential as the clinical course is extremely aggressive. In this report, we present a case of rapidly progressive PH and subsequent right ventricular (RV) failure secondary to IVLBCL. We review the important differential diagnoses and diagnostic evaluation needed to make a correct and early diagnosis. A 53-year-old, previously healthy man developed 2 months of progressive shortness of breath. After being treated for presumptive pneumonia, he was admitted with hypoxic respiratory failure, altered mental status, and severe PH. He developed RV failure and subsequent liver failure. He was ruled out for pulmonary embolism. Despite aggressive management with inhaled nitric oxide and epoprostenol, inotropes, and continuous renal replacement therapy, the patient passed away. Post-mortem examination revealed the presence of IVLBCL with extensive involvement notable of the brain, heart, lungs, and pulmonary arteries. The acute development of severe PH and RV failure in the absence of pulmonary emboli is uncommon and represents a challenging diagnostic and management clinical scenario. When accompanied by altered mental status, constitutional symptoms and an elevated lactate dehydrogenase, clinicians should have a high index of suspicion for intravascular lymphoma, as early diagnosis is critical to maintain a reasonable chance of survival.
Sections du résumé
BACKGROUND
BACKGROUND
Intravascular large B-cell lymphoma (IVLBCL) is a rare disease characterized by proliferation of malignant lymphoid cells within the small vessels of various organs resulting in diffuse thrombosis. It most commonly affects the central nervous system and the skin, but if it involves the pulmonary arteries it can cause acute severe pulmonary hypertension (PH) and right heart failure. Early diagnosis is essential as the clinical course is extremely aggressive. In this report, we present a case of rapidly progressive PH and subsequent right ventricular (RV) failure secondary to IVLBCL. We review the important differential diagnoses and diagnostic evaluation needed to make a correct and early diagnosis.
CASE SUMMARY
METHODS
A 53-year-old, previously healthy man developed 2 months of progressive shortness of breath. After being treated for presumptive pneumonia, he was admitted with hypoxic respiratory failure, altered mental status, and severe PH. He developed RV failure and subsequent liver failure. He was ruled out for pulmonary embolism. Despite aggressive management with inhaled nitric oxide and epoprostenol, inotropes, and continuous renal replacement therapy, the patient passed away. Post-mortem examination revealed the presence of IVLBCL with extensive involvement notable of the brain, heart, lungs, and pulmonary arteries.
DISCUSSION
CONCLUSIONS
The acute development of severe PH and RV failure in the absence of pulmonary emboli is uncommon and represents a challenging diagnostic and management clinical scenario. When accompanied by altered mental status, constitutional symptoms and an elevated lactate dehydrogenase, clinicians should have a high index of suspicion for intravascular lymphoma, as early diagnosis is critical to maintain a reasonable chance of survival.
Identifiants
pubmed: 31020226
doi: 10.1093/ehjcr/yty150
pii: yty150
pmc: PMC6439388
doi:
Types de publication
Case Reports
Langues
eng
Pagination
yty150Références
Int J Cardiol. 2000 Sep 15;75(2-3):283-4
pubmed: 11186959
Am J Hematol. 2005 May;79(1):46-9
pubmed: 15849762
Oncologist. 2006 May;11(5):496-502
pubmed: 16720850
Hematol Oncol. 2009 Mar;27(1):46-9
pubmed: 18819161
Lancet Oncol. 2009 Sep;10(9):895-902
pubmed: 19717091
Intern Med. 2010;49(1):51-4
pubmed: 20046001
Cancer. 1990 Aug 1;66(3):587-92
pubmed: 2163747
Arch Pathol Lab Med. 2012 Mar;136(3):333-8
pubmed: 22372911
Diagn Pathol. 2012 Jun 20;7:70
pubmed: 22716188
Cancer. 1990 Jan 15;65(2):349-53
pubmed: 2295057
Am J Surg Pathol. 1986 Feb;10(2):112-23
pubmed: 2420221
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6301-6
pubmed: 25337283
J Clin Imaging Sci. 2015 Jul 31;5:44
pubmed: 26312142
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Chest. 1989 Nov;96(5):1199-200
pubmed: 2805852
Chest. 1994 Feb;105(2):458-62
pubmed: 8306747